Results 221 to 230 of about 14,150,903 (296)

Understanding Well-Being in Daily Life: Informal Social Support, Depression Risk, and Life Satisfaction Among Chinese Older Adults with Disabilities. [PDF]

Behav Sci (Basel)
Wang X, Zhang C, Xu W, Chen S, Chen G.
europepmc   +1 more source

Geometry‐Based Neural‐Network Prediction of Electron Localization Function Topology in Dense Hydrogen

Chemistry – A European Journal, EarlyView.
We present a machine‐learning framework that predicts the electron localization function (ELF) of dense hydrogen directly from atomic geometry, bypassing explicit electronic‐structure calculations. Trained on ab initio data for fluid hydrogen across multiple pressures, the model achieves high accuracy and reveals pressure‐dependent nonlocal ...
Xiaoyu Wang, Miriam Marqués, Sergio Gómez, Francesc Serratosa, Eva Zurek, Julia Contreras‐García   +5 more
wiley   +1 more source

Modeling Farm Equipment Vehicle crash injury severity using random parameters logit and multi-class support vector machine in a developing country. [PDF]

Sci Rep
Nasab EJ, Sheikholeslami A, Vassallo JM, Moeinaddini A.   +3 more
europepmc   +1 more source

Sparse maximum likelihood estimation of regression models

Canadian Journal of Statistics, EarlyView.
Abstract For regression model selection and estimation, we study a small set of candidate models of maximum likelihood from which all information criteria such as the Akaike information criterion (AIC) and the Bayesian information criterion (BIC) choose their models.
Min Tsao
wiley   +1 more source

Population Pharmacokinetics and Exposure‐Response Analyses to Support Cofetuzumab Pelidotin (ABBV‐647) Dose Optimization in Non‐Small Cell Lung Cancer Patients

Clinical Pharmacology &Therapeutics, EarlyView.
Cofetuzumab pelidotin (Cofe‐P) is an anti‐protein tyrosine kinase 7 (PTK7) antibody‐drug conjugate (ADC) being investigated for the treatment of adults with PTK7‐expressing, recurrent non‐small cell lung cancer (NSCLC). The first‐in‐human (FIH) trial demonstrated tolerability of dosages ≤ 2.8 mg/kg once every 3 weeks (Q3W) and ≤ 3.2 mg/kg Q2W ...
Carla Biesdorf, Melanie Rinas, Benjamin Engelhardt, Rabih Saab, Cen Guo, Cristiano Ferlini, Kevin J. Freise, Rajeev M. Menon, Akshanth R. Polepally   +8 more
wiley   +1 more source

Tutorial on Analyzing Patient-Reported Outcome Measures in Clinical Development. [PDF]

Clin Transl Sci
Mehta K, Hughes JH, Zhou J, Muluneh B, Gnanasakthy A.   +4 more
europepmc   +1 more source

Viral Dynamic Model‐Informed Dose Selection of Mosnodenvir Prophylaxis against DENV‐3 in a Controlled Human Infection Model

Clinical Pharmacology &Therapeutics, EarlyView.
Dengue virus (DENV) infection is a significant global health threat. Mosnodenvir (JNJ‐64281802) is a pan‐serotype small molecule antiviral blocking DENV replication. A Phase IIa study (NCT05048875) evaluated the antiviral activity, safety, and pharmacokinetics of mosnodenvir as prophylaxis against DENV‐3 in a controlled human infection model (CHIM).
Nele Goeyvaerts, Xavier Woot de Trixhe, Martine Neyens, Thomas N. Kakuda, Liesbeth Van Wesenbeeck, Annemie Buelens, Freya Rasschaert, Anna Durbin, Oliver Ackaert   +8 more
wiley   +1 more source

The Impact of Social Participation on Health Outcomes Among Middle-Aged and Older Adults in China: Evidence from the Chinese General Social Survey. [PDF]

Healthcare (Basel)
Zhou H, Xu H.
europepmc   +1 more source

Sustainability Disclosure and External Assurance of Reports in the Italian Agrifood Sector

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT The European Union introduced the Corporate Sustainability Reporting Directive (CSRD) with the aim of aligning the “walk”—the implementation of substantive sustainability practices—and the “talk”—their representation in sustainability reporting.
Andrea Caccialanza, Mirta Casati, Marco Angelo Marinoni   +2 more
wiley   +1 more source

Factors Associated With 90-Day Functional Outcome After Neurosurgical Management of Hypertensive Intracerebral Hemorrhage. [PDF]

Brain Behav
Sulaiman AK, Ali A, Msheik A, Abdelhafiz I, Al-Sada F, Hamoud M, Al-Rumaihi G.   +6 more
europepmc   +1 more source